Literature DB >> 4834147

Combination chemotherapy of Hodgkin's disease.

D W Nison, A C Aisenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4834147     DOI： 10.1002/1097-0142(197406)33:6<1499::aid-cncr2820330605>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Chemotherapy treated Hodgkins disease--a fifteen year review.

Authors:  J P Bourke; J J Fennelly; J Duggan; E Boyle; M McCabe; P Warde; R Conroy
Journal:  Ir J Med Sci       Date:  1986-09       Impact factor: 1.568

2.  [Stage IIIB and IVB Hodgkin's disease. Response to chemotherapy, relapses, survival rates (author's transl)].

Authors:  R Kuse; A Calavrezos; A Hinrichs; K Hausmann
Journal:  Klin Wochenschr       Date:  1981-07-01

3.  Prognostic factors in COPP-treated patients with Hodgkin's disease.

Authors:  W Gassmann; L Perenyi; N Schmitz; W Kayser; H Pralle; H Löffler
Journal:  Blut       Date:  1982-06

4.  MVPP chemotherapy regimen for advanced Hodgkin's disease.

Authors:  S B Sutcliffe; P F Wrigley; J Peto; T A Lister; A G Stansfeld; J M Whitehouse; D Crowther; J S Malpas
Journal:  Br Med J       Date:  1978-03-18

5.  [Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)].

Authors:  W Gassmann; L Perenyi; H Pralle; M Graubner; N Schmitz; H Löffler
Journal:  Klin Wochenschr       Date:  1981-03-16

6.  Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.

Authors:  S B Kaye; C A Juttner; I E Smith; A Barrett; D E Austin; M J Peckham; T J McElwain
Journal:  Br J Cancer       Date:  1979-02       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.